TY - JOUR
T1 - Seroprevalence of Poliovirus Types 1, 2, and 3 Among Children Aged 6–11 Months
T2 - Variations Across Survey Rounds in High-Risk Areas of Pakistan
AU - Hussain, Imtiaz
AU - Khan, Ahmad
AU - Umer, Muhammad
AU - Sajid, Muhammad
AU - Abbas, Haider
AU - Alam, Muhammad Masroor
AU - Bosan, Altaf
AU - Partridge, Jeffrey
AU - Hafiz, Rehan
AU - Haq, Anwar Ul
AU - Soofi, Sajid
N1 - Publisher Copyright:
© 2025 by the authors.
PY - 2025/10
Y1 - 2025/10
N2 - Background: The current polio epidemiology in Pakistan poses a unique challenge for global eradication, with polio transmission dynamics influenced by regional variations in immunity and disparities in immunization coverage. This study assesses the immunity level for all three poliovirus types among children aged 6–11 months in polio high-risk regions of Pakistan. Methods: Four consecutive rounds of cross-sectional serological surveys were conducted in polio high-risk areas of Pakistan between November 2016 and October 2023. Twelve high-risk areas were covered in the first three rounds of the survey, while 44 high-risk areas were covered in the fourth round. 25 clusters from each geographical stratum were selected utilizing probability proportional to size. Results: Across the four rounds of the survey, 32,907 children aged 6–11 months from 2084 clusters and 32,371 households were covered. Comparative analysis across the survey rounds showed that seroprevalence of poliovirus type 1 was high in provinces (>95%), albeit consistently lower in Balochistan (going down to 89.7% in Round 4). Type 2 seroprevalence was significantly lower and more heterogeneous, from 34.6% in Sindh to 83.4% in Punjab, with sharp declines by round 4, particularly in Balochistan (40.4%). Type 3 seroprevalence was overall high (>94% in Punjab, Sindh, and KPK) but dropped in the last round, while Balochistan exhibited continually lower immunity (81.1%). Conclusions: The findings reflect the variations in population immunity to poliovirus in the country, with notable fluctuations over the years. The gaps in type 2 immunity over time and consistently lowest in Balochistan highlight the need for continued monitoring of immunity levels and adaptable vaccination strategies.
AB - Background: The current polio epidemiology in Pakistan poses a unique challenge for global eradication, with polio transmission dynamics influenced by regional variations in immunity and disparities in immunization coverage. This study assesses the immunity level for all three poliovirus types among children aged 6–11 months in polio high-risk regions of Pakistan. Methods: Four consecutive rounds of cross-sectional serological surveys were conducted in polio high-risk areas of Pakistan between November 2016 and October 2023. Twelve high-risk areas were covered in the first three rounds of the survey, while 44 high-risk areas were covered in the fourth round. 25 clusters from each geographical stratum were selected utilizing probability proportional to size. Results: Across the four rounds of the survey, 32,907 children aged 6–11 months from 2084 clusters and 32,371 households were covered. Comparative analysis across the survey rounds showed that seroprevalence of poliovirus type 1 was high in provinces (>95%), albeit consistently lower in Balochistan (going down to 89.7% in Round 4). Type 2 seroprevalence was significantly lower and more heterogeneous, from 34.6% in Sindh to 83.4% in Punjab, with sharp declines by round 4, particularly in Balochistan (40.4%). Type 3 seroprevalence was overall high (>94% in Punjab, Sindh, and KPK) but dropped in the last round, while Balochistan exhibited continually lower immunity (81.1%). Conclusions: The findings reflect the variations in population immunity to poliovirus in the country, with notable fluctuations over the years. The gaps in type 2 immunity over time and consistently lowest in Balochistan highlight the need for continued monitoring of immunity levels and adaptable vaccination strategies.
KW - children 6–11 months
KW - Pakistan
KW - poliovirus seroprevalence
KW - population immunity
KW - serological surveys
KW - serotype immunity
UR - https://www.scopus.com/pages/publications/105020063620
U2 - 10.3390/vaccines13101067
DO - 10.3390/vaccines13101067
M3 - Article
AN - SCOPUS:105020063620
SN - 2076-393X
VL - 13
JO - Vaccines
JF - Vaccines
IS - 10
M1 - 1067
ER -